首頁 › 紅斑性狼瘡 › 紐約州 › New York City
New York City, NY 的 紅斑性狼瘡 臨床試驗
18 項針對 紅斑性狼瘡 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
招募中2 期
- Columbia University Medical Center, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
招募中3 期
- Sl0044 50077, New York
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
招募中3 期
- Research Site, New York
HEALTH Home Urinalysis Testing
招募中
- NYU Langone Health, New York
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
招募中1/2 期
- Research Site, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
招募中4 期
- New York University School Of Medicine, New York
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
招募中2 期
- Icahn School of Medicine at Mount Sinai, New York
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
招募中3 期
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- 還有 2 項
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
招募中2 期
- NYU Langone Health, New York
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
招募中1 期
- Columbia University Medical Center, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Montefiore Medical Center, New York
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
招募中觀察性研究歡迎健康志工
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Alnuctamab for Refractory SLE (LATTE Study)
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
Lupus Landmark Study: A Prospective Registry and Biorepository
招募中觀察性研究
- Columbia University Medical Center, New York
- Northwell Health, New York
Safety of the Herpes Zoster Subunit Vaccine in Lupus
招募中4 期
- NYU Langone Health, New York
Safety and Efficacy of ONT01 in Lupus
招募中早期第 1 期
- Hospital for Special Surgery, New York
其他城市的 紅斑性狼瘡 試驗
- Houston, TX13 項研究
- Durham, NC12 項研究
- Miami, FL11 項研究
- Washington, DC10 項研究
- Tampa, FL9 項研究
- Philadelphia, PA9 項研究
- Clearwater, FL8 項研究
- Santa Monica, CA8 項研究
- Oklahoma City, OK8 項研究
- Los Angeles, CA8 項研究
- Chicago, IL8 項研究
- Boston, MA8 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症（所有類型）109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。